Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director · Chairman and CEO | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 62,442 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 21,812 · Balance 62,442 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2020 Filed Sep 17, 2020 01:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,937 | $168.10 | $325,609.70 |
DisclosureSEC source: 0001156375-20-000091 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,066 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:00 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 26,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000103 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,939 Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 01:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,546 | $166.08 | $256,759.68 |
DisclosureSEC source: 0001156375-20-000091 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,003 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2020. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 470 | $182.01 | $85,544.70 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 7 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,549 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/20. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 10 | $182.01 | $1,820.10 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 6 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,019 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/20. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 591 | $182.01 | $107,567.91 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 5 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,029 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/20. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 9,122 | $182.01 | $1,660,295.22 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,620 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 20,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,742 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 9,122 | $182.01 | $1,660,295.22 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,152 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 20,590 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000020 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,274 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:31 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 39,309 | $202.38 | $7,955,355.42 |
DisclosureSEC source: 0001156375-19-000116 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,684 F1 · price: On December 12, 2019, Mr. Duffy sold an aggregate of 39,309 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $202.00 to $202.95 and $203.25 to $203.54. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 22:31 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 12,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000097 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,993 Read SEC document |
| September 15, 2019 Filed Sep 17, 2019 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,066 | $205.80 | $425,182.80 |
DisclosureSEC source: 0001156375-19-000097 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,313 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2019. Read SEC document |
| September 15, 2019 Filed Sep 17, 2019 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,047 | $205.80 | $421,272.60 |
DisclosureSEC source: 0001156375-19-000097 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,379 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2019. Read SEC document |
| September 14, 2019 Filed Sep 17, 2019 22:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,631 | $205.80 | $335,659.80 |
DisclosureSEC source: 0001156375-19-000097 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,426 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2019. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 21:01 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 35,000 | $200.15 | $7,005,250.00 |
DisclosureSEC source: 0001156375-19-000083 · primary_doc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,057 F1 · price: On August 1, 2019, Mr. Duffy sold an aggregate of 35,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $200.13 to $200.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 7 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,057 F4 · shares: On March 15, 2019, Mr. Duffy received a performance grant of 4,408 shares of restricted stock based upon the company's achievement of relative total shareholder return relative to the S&P 500 for 2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 613 | $170.14 | $104,295.82 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 6 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,649 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/19. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 10 | $170.14 | $1,701.40 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 5 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,262 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/19. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 5,814 | $170.14 | $989,193.96 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,272 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 13,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,086 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 5,814 | $170.14 | $989,193.96 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,962 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 13,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000019 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,776 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 20:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 10,000 | $188.80 | $1,888,000.00 |
DisclosureSEC source: 0001156375-18-000135 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,652 F1 · price: On November 23, 2018, Mr. Duffy sold an aggregate of 10,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $188.76 to $188.98. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:09 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,114 | $173.15 | $366,039.10 |
DisclosureSEC source: 0001156375-18-000090 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,652 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 15, 2018 Filed Sep 18, 2018 22:09 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,080 | $173.15 | $360,152.00 |
DisclosureSEC source: 0001156375-18-000090 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,766 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/18. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 22:09 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 15,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000090 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,846 Read SEC document |
| May 22, 2018 Filed May 23, 2018 19:38 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 20,000 | $161.00 | $3,220,000.00 |
DisclosureSEC source: 0001156375-18-000050 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,686 F1 · price: On May 22, 2018, Mr. Duffy sold an aggregate of 20,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $161.00 to $161.13. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:30 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000031 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,686 F4 · shares: On March 15, 2018, Mr. Duffy received a performance grant of 92 shares of restricted stock based upon the company's achievement of relative total shareholder return relative to the S&P 500 for 2017. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:30 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 635 | $165.66 | $105,194.10 |
DisclosureSEC source: 0001156375-18-000031 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,594 F3 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/18. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:30 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 12,720 | $165.66 | $2,107,195.20 |
DisclosureSEC source: 0001156375-18-000031 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,229 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 22:30 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 28,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000031 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,949 F1 · shares: Represents shares earned from a 2014 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2015-2017. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 20:50 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 20,000 | $151.66 | $3,033,200.00 |
DisclosureSEC source: 0001156375-18-000013 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,239 F1 · price: On February 6, 2018, Mr. Duffy sold an aggregate of 20,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $150.68 to $150.89; $151.00 to $151.69; and $154.00 to $154.01. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 23:00 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,564 | $146.05 | $228,422.20 |
DisclosureSEC source: 0001156375-18-000001 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,239 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/17. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 23:00 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,358 | $146.05 | $198,335.90 |
DisclosureSEC source: 0001156375-18-000001 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,803 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/17. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 23:00 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,358 | $146.05 | $198,335.90 |
DisclosureSEC source: 0001156375-18-000001 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,161 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/17. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 23:00 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 411 | $146.05 | $60,026.55 |
DisclosureSEC source: 0001156375-18-000001 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,519 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/17. Read SEC document |
| September 16, 2017 Filed Sep 19, 2017 18:35 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,488 | $131.29 | $195,359.52 |
DisclosureSEC source: 0001156375-17-000092 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,930 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 5,285 | $131.29 | $693,867.65 |
DisclosureSEC source: 0001156375-17-000092 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,418 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/17. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 18:35 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 19,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000092 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,703 Read SEC document |
| August 02, 2017 Filed Aug 3, 2017 20:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 21,815 | $123.89 | $2,702,660.35 |
DisclosureSEC source: 0001156375-17-000081 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,711 F1 · price: On August 2, 2017, Mr. Duffy sold an aggregate of 21,815 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.80 to $123.99 and $124.19 to $124.22. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:35 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000027 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,526 F3 · shares: On March 15, 2017, Mr. Duffy received a grant of 6,012 shares of restricted stock based upon 2016 TSR performance as measured against the S&P 500. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:35 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 30,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000027 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,514 F2 · shares: Represents shares earned from a 2013 performance share award based upon the company's achievement of cash earnings per share growth and total shareholder return relative to the S&P 500 measured over 2014-2016. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:35 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 13,938 | $124.74 | $1,738,626.12 |
DisclosureSEC source: 0001156375-17-000027 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,018 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 14, 2017 Filed Mar 15, 2017 20:55 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 408 | $124.45 | $50,775.60 |
DisclosureSEC source: 0001156375-17-000024 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,956 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/14/2017. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 21:36 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 27,550 | $0.00 Strike: $110.54 | $0.00 |
DisclosureSEC source: 0001156375-16-000260 · edgardoc.xml · derivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 27,550 shares Expires 2017-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 21:36 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 27,550 | $120.44 | $3,317,992.52 |
DisclosureSEC source: 0001156375-16-000260 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,364 F1 · price: On December 8, 2016, Mr. Duffy sold an aggregate of 27,550 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $120.14 to $120.76. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 21:36 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 27,550 | $110.54 | $3,045,377.00 |
DisclosureSEC source: 0001156375-16-000260 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 22:27 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 17,375 | $0.00 Strike: $105.90 | $0.00 |
DisclosureSEC source: 0001156375-16-000256 · edgardoc.xml · derivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 17,375 shares Expires 2016-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of December 15, 2011, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 22:27 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 17,375 | $112.58 | $1,956,077.50 |
DisclosureSEC source: 0001156375-16-000256 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,364 F1 · price: On November 25, 2016, Mr. Duffy sold an aggregate of 17,375 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $112.55 to $112.61. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.